roche glp-1 drug How Receptor Agonists Evolved from Diabetes to Weight Loss Treatments RO OFFERS ELI LILLY'S FOUNDAYO™,

Edith Lahner, Sapienza University of Rome, Department of Medical-surgical sciences and translational medicine, Italy

Transforming growth factor- receptors: versatile mechanisms of ligand activation

doi: 10.4065/mcp.2009.0534 82

[PubMed] [Google Scholar] [60].Kurtzhals P, Havelund S, Jonassen I, Kiehr B, Larsen UD, Ribel U, Markussen J, Albumin binding of insulins acylated with fatty acids: characterization of the ligand-protein interaction and correlation between binding affinity and timing of the insulin effect in vivo, The Biochemical journal, 312 ( Pt 3) (1995) 725731

Ferroptosis induction improves the sensitivity of docetaxel in prostate cancer